CXCL2 and glaucoma: Several cellular junction proteins maintain the BRB, and during bacterial infection and other ocular inflammation models (e.g., uveitis and glaucoma), increased inflammatory mediators (e.g., IL-6, MIP2, TNF-α, and IL-1β) can impair the barrier properties (24, 62, –, 66).